Stewart Noble, Vice President of Chemistry, came to Kalypsys from Pharmacia where he served as Senior Director of Chemistry with responsibility for programs targeting arthritis, inflammation, pain and ophthalmology. Prior to joining Pharmacia, Dr. Noble's industry experience included senior positions at G.D. Searle, Synaptic Pharmaceutical Corporation and Glaxo, Inc. He has 22 years experience in small molecule drug discovery and has contributed to the discovery and development of fifteen product candidates, including the HIV/HBV drug Epivir (R). He is author or coauthor of more than 70 peer reviewed scientific papers and patents. Dr. Noble is a member of the Board of Directors of Micell Technologies, Inc.